These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30446221)

  • 1. Alleviation of fatty liver in a rat model by enhancing N
    Takeuchi K; Yokouchi C; Goto H; Umehara K; Yamada H; Ishii Y
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):203-210. PubMed ID: 30446221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of fatty liver in rats by nicotinamide via the regeneration of the methionine cycle and the inhibition of aldehyde oxidase.
    Yokouchi C; Nishimura Y; Goto H; Sato M; Hidoh Y; Takeuchi K; Ishii Y
    J Toxicol Sci; 2021; 46(1):31-42. PubMed ID: 33408299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential involvement of IL-6 in the early and late phase of 1-methylnicotinamide (MNA) release in Concanavalin A-induced hepatitis.
    Sternak M; Jakubowski A; Czarnowska E; Slominska EM; Smolenski RT; Szafarz M; Walczak M; Sitek B; Wojcik T; Jasztal A; Kaminski K; Chlopicki S
    Int Immunopharmacol; 2015 Sep; 28(1):105-14. PubMed ID: 25976094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the nicotinamide N-methyltransferase (NNMT)-1-methylnicotinamide (MNA) pathway in pulmonary hypertension.
    Fedorowicz A; Mateuszuk Ł; Kopec G; Skórka T; Kutryb-Zając B; Zakrzewska A; Walczak M; Jakubowski A; Łomnicka M; Słomińska E; Chlopicki S
    Respir Res; 2016 Aug; 17(1):108. PubMed ID: 27581040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotinamide N-methyltransferase (NNMT) and 1-methylnicotinamide (MNA) in experimental hepatitis induced by concanavalin A in the mouse.
    Sternak M; Khomich TI; Jakubowski A; Szafarz M; Szczepański W; Białas M; Stojak M; Szymura-Oleksiak J; Chłopicki S
    Pharmacol Rep; 2010; 62(3):483-93. PubMed ID: 20631412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
    Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
    Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotinamide overload may play a role in the development of type 2 diabetes.
    Zhou SS; Li D; Sun WP; Guo M; Lun YZ; Zhou YM; Xiao FC; Jing LX; Sun SX; Zhang LB; Luo N; Bian FN; Zou W; Dong LB; Zhao ZG; Li SF; Gong XJ; Yu ZG; Sun CB; Zheng CL; Jiang DJ; Li ZN
    World J Gastroenterol; 2009 Dec; 15(45):5674-84. PubMed ID: 19960564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of nicotinamide N-methyltrasferase and increased formation of 1-methylnicotinamide (MNA) in atherosclerosis.
    Mateuszuk Ł; Khomich TI; Słomińska E; Gajda M; Wójcik L; Łomnicka M; Gwóźdź P; Chłopicki S
    Pharmacol Rep; 2009; 61(1):76-85. PubMed ID: 19307695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-Methylnicotinamide ameliorates lipotoxicity-induced oxidative stress and cell death in kidney proximal tubular cells.
    Tanaka Y; Kume S; Araki H; Nakazawa J; Chin-Kanasaki M; Araki S; Nakagawa F; Koya D; Haneda M; Maegawa H; Uzu T
    Free Radic Biol Med; 2015 Dec; 89():831-41. PubMed ID: 26482866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental changes of aldehyde oxidase in postnatal rat liver.
    Tayama Y; Moriyasu A; Sugihara K; Ohta S; Kitamura S
    Drug Metab Pharmacokinet; 2007 Apr; 22(2):119-24. PubMed ID: 17495419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldehyde oxidase-catalyzed metabolism of N1-methylnicotinamide in vivo and in vitro in chimeric mice with humanized liver.
    Kitamura S; Nitta K; Tayama Y; Tanoue C; Sugihara K; Inoue T; Horie T; Ohta S
    Drug Metab Dispos; 2008 Jul; 36(7):1202-5. PubMed ID: 18332084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single bout of endurance exercise increases NNMT activity in the liver and MNA concentration in plasma; the role of IL-6.
    Chłopicki S; Kurdziel M; Sternak M; Szafarz M; Szymura-Oleksiak J; Kamiński K; Żołądź JA
    Pharmacol Rep; 2012; 64(2):369-76. PubMed ID: 22661188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPLC-UV method for measuring nicotinamide N-methyltransferase activity in biological samples: evidence for substrate inhibition kinetics.
    Patel M; Vasaya MM; Asker D; Parsons RB
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Mar; 921-922():87-95. PubMed ID: 23435346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance.
    Kannt A; Pfenninger A; Teichert L; Tönjes A; Dietrich A; Schön MR; Klöting N; Blüher M
    Diabetologia; 2015 Apr; 58(4):799-808. PubMed ID: 25596852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zebularine metabolism by aldehyde oxidase in hepatic cytosol from humans, monkeys, dogs, rats, and mice: influence of sex and inhibitors.
    Klecker RW; Cysyk RL; Collins JM
    Bioorg Med Chem; 2006 Jan; 14(1):62-6. PubMed ID: 16143537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxic effects of nicotinamide methylation on mouse brain striatum neuronal cells and its relation to manganese.
    Mori Y; Sugawara A; Tsuji M; Kakamu T; Tsuboi S; Kanda H; Hayakawa T; Fukushima T
    Environ Health Prev Med; 2012 Sep; 17(5):371-6. PubMed ID: 22249857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of aldehyde oxidase activity in vivo from conversion ratio of N1-methylnicotinamide to pyridones, and intraspecies variation of the enzyme activity in rats.
    Sugihara K; Tayama Y; Shimomiya K; Yoshimoto D; Ohta S; Kitamura S
    Drug Metab Dispos; 2006 Feb; 34(2):208-12. PubMed ID: 16299165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma elevates nicotinamide N-methyltransferase activity and nicotinamide level in human glioma cells.
    Yamada K; Miyazaki T; Hara N; Tsuchiya M
    J Nutr Sci Vitaminol (Tokyo); 2010; 56(2):83-6. PubMed ID: 20495288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NNMT activation can contribute to the development of fatty liver disease by modulating the NAD
    Komatsu M; Kanda T; Urai H; Kurokochi A; Kitahama R; Shigaki S; Ono T; Yukioka H; Hasegawa K; Tokuyama H; Kawabe H; Wakino S; Itoh H
    Sci Rep; 2018 Jun; 8(1):8637. PubMed ID: 29872122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent Inhibition of Nicotinamide
    Gao Y; van Haren MJ; Buijs N; Innocenti P; Zhang Y; Sartini D; Campagna R; Emanuelli M; Parsons RB; Jespers W; Gutiérrez-de-Terán H; van Westen GJP; Martin NI
    J Med Chem; 2021 Sep; 64(17):12938-12963. PubMed ID: 34424711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.